|
시장보고서
상품코드
2055002
부비동염 치료제 시장 : 약물 종류별, 투여 경로별, 제형별, 처방 상황별, 환자 연령층별, 질환 유형별, 유통 채널별, 최종사용자별, 지역별Sinusitis Drugs Market, By Drug Class, By Route of Administration, By Dosage Form, By Prescription Status, By Patient Age Group, By Disease Type, By Distribution Channel, By End User, By Geography |
||||||
부비동염 치료제 시장은 2026년에 33억 1,000만 달러로 추정되며, 2033년에 51억 1,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 33억 1,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간 CAGR: | 6.40% | 2033년 시장 규모 예측: | 51억 1,000만 달러 |
전 세계 부비동염 치료제 시장은 제약 산업에서 매우 중요한 분야로, 전 세계 수백만 명의 사람들에게 영향을 미치는 가장 흔한 호흡기질환 중 하나를 치료합니다. 부비동 염증을 특징으로 하는 부비동염은 급성과 만성의 형태로 나타나며, 효과적인 치료법에 대한 큰 수요를 낳고 있습니다.
이 질환은 매년 전 세계 인구의 약 12-15%에 영향을 미치고 있으며, 특히 만성 부비동염은 삶의 질을 저하시키고 의료 시스템에 막대한 부담을 주고 있습니다. 이 시장에는 항생제, 코르티코스테로이드, 충혈 완화제, 항히스타민제 외에도, 부비동 염증의 근본적인 다양한 병태생리학적 기전에 대응하기 위해 고안된 새로운 표적 치료법 등 다양한 치료법이 포함되어 있습니다.
호흡기 알레르기 유병률의 증가, 환경 오염, 생활 습관 요인이 특히 도시 지역 인구의 발병률 증가에 기여하고 있습니다. 시장 상황은 환자의 복약 순응도와 치료 성과 향상을 목표로 하는 정맥주사제, 경구제, 첨단 세척액 등 혁신적인 약물전달 시스템에 힘입어 진화하고 있습니다. 의료 종사자들은 치료되지 않은 부비동염이 초래하는 생산성 저하 및 반복적인 의료 이용 등 경제적 영향을 점점 더 인식하고 있으며, 이는 보다 효과적인 치료법에 대한 수요를 촉진하고 있습니다.
시장 역학
전 세계 부비동염 치료제 시장은 치료 부문 전반에 걸쳐 견실한 성장 기회를 창출하는 몇 가지 주요 촉진요인에 힘입어 성장하고 있습니다. 주요 원인은 대기 오염의 악화, 도시화, 부비동 염증을 유발하기 쉬운 호흡기 알레르기 발생률의 증가로 인한 전 세계 부비동염 유병률의 상승에 있습니다.
건강 증진 캠페인과 진단 능력의 향상으로 조기 발견과 조기 치료가 가능해지면서, 약물 치료를 원하는 환자층이 확대되고 있습니다. 고령자는 만성 부비동염 및 관련 합병증에 걸리기 쉬우므로, 전 세계적인 고령화 또한 중요한 성장 요인으로 작용하고 있습니다. 그러나 시장에는 성장 궤도를 저해할 수 있는 뚜렷한 제약요인이 존재합니다.
제네릭 의약품의 시장 침투는 브랜드 의약품에 가격 면에서 압박을 가하고 있는 반면, 엄격한 규제 승인 절차는 혁신적인 치료법의 시장 진입을 지연시키고 있습니다. 또한, 외과적 개입이나 대체 의학 접근법을 포함한 비약물적 치료에 대한 선호는 특정 환자 집단에서 의약품 시장의 성장을 제한할 가능성이 있습니다. 항생제 내성에 대한 우려로 인해, 특히 세균성 부비동염의 경우 처방 패턴이 제한되고 있습니다.
이러한 과제가 있음에도 불구하고, 시장 상황에는 큰 기회가 존재합니다. 특정 염증 경로에 작용하는 표적 치료법의 개발은 연구 개발에 투자하는 제약 기업들에게 유망한 전망을 제시하고 있습니다. 아시아태평양 및 라틴아메리카 신흥 시장에서는 의료 인프라 개선과 의료비 증가에 따라 미개척 성장 기회가 기대됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 부비동염 치료제 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 부비동염 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 부비동염 치료제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 부비동염 치료제 시장 : 약물 종류별, 2021-2033년
제5장 세계의 부비동염 치료제 시장 : 투여 경로별, 2021-2033년
제6장 세계의 부비동염 치료제 시장 : 제형별, 2021-2033년
제7장 세계의 부비동염 치료제 시장 : 처방 상황별, 2021-2033년
제8장 세계의 부비동염 치료제 시장 : 환자 연령층별, 2021-2033년
제9장 세계의 부비동염 치료제 시장 : 질환 유형별, 2021-2033년
제10장 세계의 부비동염 치료제 시장 : 유통 채널별, 2021-2033년
제11장 세계의 부비동염 치료제 시장 : 최종사용자별, 2021-2033년
제12장 세계의 부비동염 치료제 시장 : 지역별, 2021-2033년
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고문헌과 조사 방법
KSM 26.06.18Sinusitis Drugs Market is estimated to be valued at USD 3.31 Bn in 2026 and is expected to reach USD 5.11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.31 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.40% | 2033 Value Projection: | USD 5.11 Bn |
The global sinusitis drugs market represents a critical segment within the pharmaceutical industry, addressing one of the most prevalent respiratory conditions affecting millions of individuals worldwide. Sinusitis, characterized by inflammation of the paranasal sinuses, manifests in acute and chronic forms, creating substantial demand for effective therapeutic interventions.
The condition affects approximately 12-15% of the global population annually, with chronic sinusitis impacting quality of life and imposing significant healthcare burdens. The market encompasses various therapeutic classes including antibiotics, corticosteroids, decongestants, antihistamines, and emerging targeted therapies designed to address different pathophysiological mechanisms underlying sinus inflammation.
Rising prevalence of respiratory allergies, environmental pollution, and lifestyle factors contribute to increased incidence rates, particularly in urban populations. The market landscape is evolving with innovative drug delivery systems, including nasal sprays, oral formulations, and advanced irrigation solutions, aimed at improving patient compliance and therapeutic outcomes. Healthcare providers increasingly recognize the economic impact of untreated sinusitis, including productivity losses and recurrent healthcare utilization, driving demand for more effective treatment options.
Market Dynamics
The global sinusitis drugs market is propelled by several key drivers that create robust growth opportunities across therapeutic segments. The primary driver stems from increasing prevalence of sinusitis conditions worldwide, attributed to rising air pollution levels, urbanization, and growing incidence of respiratory allergies that predispose individuals to sinus inflammation.
Healthcare awareness campaigns and improved diagnostic capabilities enable earlier detection and treatment initiation, expanding the patient pool seeking pharmaceutical interventions. The aging global population represents another significant growth driver, as elderly individuals demonstrate higher susceptibility to chronic sinusitis and related complications. However, the market faces notable restraints that could impede growth trajectories.
Generic drug penetration poses pricing pressures on branded pharmaceutical products, while stringent regulatory approval processes delay market entry of innovative therapies. Additionally, the preference for non-pharmacological treatments, including surgical interventions and alternative medicine approaches, may limit pharmaceutical market expansion in certain patient populations. Antibiotic resistance concerns also restrict prescribing patterns, particularly for bacterial sinusitis cases.
Despite these challenges, substantial opportunities exist within the market landscape. The development of targeted therapies addressing specific inflammatory pathways presents lucrative prospects for pharmaceutical companies investing in research and development. Emerging markets in Asia-Pacific and Latin America offer untapped growth potential due to improving healthcare infrastructure and increasing healthcare expenditure.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global sinusitis drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, GlaxoSmithKline plc, Sanofi, Regeneron Pharmaceuticals Inc, AstraZeneca plc, Novartis AG, Johnson and Johnson, Bayer AG, Merck and Co Inc, F. Hoffmann La Roche Ltd, AbbVie Inc, Teva Pharmaceutical Industries Ltd, Allergan plc (now part of AbbVie), Sun Pharmaceutical Industries Ltd, and Dr Reddys Laboratories Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global sinusitis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sinusitis drugs market
Market Segmentation
- Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Antibiotics
- Corticosteroids
- Antihistamines
- Decongestants
- Analgesics/Pain Relievers
- Antifungal Agents
- Saline Nasal Sprays
- Immunotherapy Drugs
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Nasal (Spray / Drops)
- Parenteral (Injection / IV)
- Topical
- Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)
- Tablets
- Capsules
- Sprays
- Drops
- Syrups/Liquids
- Inhalers
- Prescription Status Insights (Revenue, USD Bn, 2021 - 2033)
- Prescription-only (Rx)
- Over-the-counter (OTC)
- Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Acute Sinusitis
- Subacute Sinusitis
- Chronic Sinusitis
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Homecare Settings
- Specialty Centers
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- GlaxoSmithKline plc
- Sanofi
- Regeneron Pharmaceuticals Inc
- AstraZeneca plc
- Novartis AG
- Johnson & Johnson
- Bayer AG
- Merck & Co Inc
- Hoffmann La Roche Ltd
- AbbVie Inc
- Teva Pharmaceutical Industries Ltd
- Allergan plc (now part of AbbVie)
- Sun Pharmaceutical Industries Ltd
- Dr Reddys Laboratories Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sinusitis Drugs Market, By Drug Class
- Global Sinusitis Drugs Market, By Route of Administration
- Global Sinusitis Drugs Market, By Dosage Form
- Global Sinusitis Drugs Market, By Prescription Status
- Global Sinusitis Drugs Market, By Patient Age Group
- Global Sinusitis Drugs Market, By Disease Type
- Global Sinusitis Drugs Market, By Distribution Channel
- Global Sinusitis Drugs Market, By End User
- Global Sinusitis Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Sinusitis Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Analgesics/Pain Relievers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antifungal Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Saline Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunotherapy Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Sinusitis Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nasal (Spray / Drops)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral (Injection / IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Sinusitis Drugs Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Syrups/Liquids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Sinusitis Drugs Market, By Prescription Status, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription-only (Rx)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Over-the-counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Sinusitis Drugs Market, By Patient Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Sinusitis Drugs Market, By Disease Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Acute Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Subacute Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Sinusitis Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Sinusitis Drugs Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Sinusitis Drugs Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regeneron Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan plc (now part of AbbVie)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr Reddys Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
